期刊文献+

Gates法测定2型糖尿病肾病患者肾小球滤过率 被引量:12

Evaluation of 99Tcm-DTPA glomerular fdtration rate by the Gates method in patients with type 2 diabetes
原文传递
导出
摘要 目的探讨2型糖尿病肾病患者^99Tc^m-DTPAGFR测定的时间影响及GFR对2型糖尿病肾功能异常早期诊断的临床意义。方法招募健康志愿者11名,其中男6名,女5名,年龄47~79(61.45±7.90)岁;社区2型糖尿病肾病患者56例,其中男31例,女25例,年龄45~75(60.98±6.96)岁,均应用^99Tc^m-DTPA肾动态显像测定GFR。分别取注药后第2分钟和第3分钟图像勾画ROI,根据Gates分析方法,计算总肾及分肾GFR。利用SPSS15.0软件对数据进行Pearson相关分析和两样本t检验。结果2型糖尿病肾病患者的GFR与SCr[(84.90±14.38)bunol/L]呈负相关:注射^99Tc^m-DTPA后第2分钟双肾、左肾和右肾GFR均与SCr呈负相关(r=-0.599、-0.553和-0.529,均P〈0.001);第3分钟双肾、左。肾和右肾GFR也均与SCr呈负相关(r=-0.652、-0.636和-0.470,均P≤0.001)。2型糖尿病。肾病患者双肾、左肾和右肾第3分钟GFR分别为(69.77±11.00)、(33.12±5.74)和(37.34±9.81)ml/min,低于健康对照组[(97.89±5.98)、(46.60±4.91)和(51.28±4.20)ml/min;t=-8.212、-7.233和-4.069,均P〈0.001]。结论建议对2型糖尿病肾病患者选择注射^99Tc^m-DTPA后第3分钟的放射性计数测定GFR;GFR测定对糖尿病肾病患者肾功能异常早期诊断具有重要意义。 Objective To study the changes of GFR measured in different time intervals after the injection of 99Tcm-DTPA and to evaluate the clinical value of GFR in patients with type 2 diabetes. Methods Eleven healthy volunteers ( 6 males, 5 females ; mean age ( 61.45± 7.90) years, age range : 47- 79 years ) and 56 patients with type 2 diabetes (31 males, 25 females; mean age (60.98±6.96) years, age range: 45- 75 years) were recruited. 99Tcm-DTPA was used to measure GFR for all subjects. ROI was drawn at 2 and 3 rain post-injection and GFR was calculated by Gates method. Two-sample t test and Pearson correlation analysis were performed with SPSS 15.0. Results SCr ((84.90±14.38) μmol/L) was significantly correlated with GFR in patients with type 2 diabetes. There was negative correlation between SCr and GFR for both, left and right kidneys at 3 min post-injection (r=-0.652, -0.636, -0.470, all P≤0.001) and at 2 rain post-injection (r=-0.599, -0.553, -0.529, all P〈0.001). Total GFR, GFR for left kidney and GFR for right kidney at 3 rain post-injection in diabetes group ( ( 69.77± 11.00 ) , ( 33.12 ± 5.74 ) , ( 37.34 ± 9.81 ) ml/min) were lower than those in control group ( (97.89±5.98), (46.60±4.91), (51.28±4.20) ml/min; t=-8.212, -7.233, -4.069, all P〈0.001). Conclusions To calculate the GFR of the patients with type 2 diabetes, 3 rain post-injection is the optimal time. Measurement of GFR by 99Tcm-DTPA is useful in early diagnosis of diabetic nephropathy.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2013年第5期355-357,共3页 Chinese Journal of Nuclear Medicine and Molecular Imaging
关键词 糖尿病肾病 肾小球滤过率 Gates法 放射性核素显像 DTPA Diabetic nephropathies Glomerular filtration rate Gates method Radionuclide imaging DTPA
  • 相关文献

参考文献9

  • 1杨永珍 陈曼.核素肾小球滤过率测定的临床应用.中华核医学杂志,1995,15(4):235-235.
  • 2Stevens LA, Coresh J, Greene T, et al. Assessing kidney function- measured and estimated glomerular filtration rate. N Engl J Med, 2006, 354: 2473-2483.
  • 3Carlsen O. The gamma camera as an absolute measurement device: determination of glomerular filtration rate in 99Tem-DTPA renogra- phy using a dual head gamma camera. Nucl Med Commun, 2004, 25 : 1021-1029.
  • 4Jawa A, Keomt J, Fonseea VA. Diabetic nephropathy and retinopa- thy. Med Clin North Am, 2004, 88: 1001-1036.
  • 5Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mel- litus. N Engl J Med, 1999, 341: 1127-1133.
  • 6陈雪红,王正江,柳江燕,鲁秀娟,袁耿彪,冯建中,李西焕.GFR和ERPF与早期糖尿病肾病尿微量蛋白相关性研究[J].中华核医学杂志,2003,23(S1):48-50. 被引量:6
  • 7胡鹏程,石洪成,顾宇参,陈曙光,修雁,李蓓蕾,朱玮珉.Gates法测定肾小球滤过率的精确性及与病理对照分析[J].中华核医学杂志,2011,31(2):134-137. 被引量:2
  • 8姚建,陈名道.糖尿病肾病及其早期防治[J].中华内分泌代谢杂志,2002,18(4):330-331. 被引量:260
  • 9Kong AP, So WY, Szeto CC, et al. Assessment of glomerular fil- tration rate in addition to albuminuria is important in managing type diabetes. Kidney Int, 2006, 69: 383-387.

二级参考文献16

  • 1Gates GF.Glomerular filtration rate:estimation from fractional renal accumulation of ^99Tc^m-DTPA(stannous).Am J Roentgenol,1982,138:565-570.
  • 2De Santo NG,Anastasio P,Cirillo M,et al.Measurement of glomerular filtration rate by the ^99Tc^m-DTPA renogram is less precise than measured and predicted creatinine clearance.Nephron,1999,81:136-140.
  • 3Cockcroft DW,Gault MH.Prediction of creatinine clearance from serum creatinine.Nephron,1976,16:31-41.
  • 4Mathew TH,Australasian Creatinine Consensus Working Group.Chronic kidney disease and automatic reporting of estimated glomerular filtration rate:a position statement.Med J Aust,2005,183:138-141.
  • 5Katafuchi R,Kiyoshi Y,Oh Y,etal.Glomerular score ss a prognosticator in IgA nephropathy:its usefulness and limitation.Clin Nephrol,1998,49:1-8.
  • 6Kasiske BL,Keane WF.Laboratory assessment of renal disease:clearance,urinalysis,and renal biopsy//Brenner BM,Rector FC.The Kidney.5th ed.Philadephia:PA,Sauders,1996:1137-1173.
  • 7Perrone RD,Madias NE,Levey AS.Serum creatinine as an index of renal function:new insights into old concepts.Clin Chem,1992,38:1933-1953.
  • 8Levey AS.Use of glomerular filtration rate messurements to assess the progression of renal disease.Semin Nephrol,1989,9:370-379.
  • 9Rodríguez-Iturbe B,García García G.The role of tubulointerstitial inflammation in the progression of chronic renal failure.Nephron Clin Pract,2010,116:c81-88.
  • 10A. R. Andersen,J. Sandahl Christiansen,J. K. Andersen,S. Kreiner,T. Deckert. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study[J] 1983,Diabetologia(6):496~501

共引文献274

同被引文献77

引证文献12

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部